APA (7th ed.) Citation

Tu, A., Zhu, X., Dastjerdi, P. Z., Yin, Y., Peng, M., Zheng, D., . . . Jing, W. (2024). Evaluate the clinical efficacy of traditional Chinese medicine as the neoadjuvant treatment in reducing the incidence of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis: A systematic review and meta-analysis. Elsevier Ltd.

Chicago Style (17th ed.) Citation

Tu, An, et al. Evaluate the Clinical Efficacy of Traditional Chinese Medicine as the Neoadjuvant Treatment in Reducing the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B-related Cirrhosis: A Systematic Review and Meta-analysis. Elsevier Ltd, 2024.

MLA (9th ed.) Citation

Tu, An, et al. Evaluate the Clinical Efficacy of Traditional Chinese Medicine as the Neoadjuvant Treatment in Reducing the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B-related Cirrhosis: A Systematic Review and Meta-analysis. Elsevier Ltd, 2024.